Regeneron (NASDAQ: REGN) Falls 11% as Pipeline Uncertainty and Margin Pressure Weigh on Investors
Regeneron Pharmaceuticals dropped more than 11% on Monday, wiping $77.25 off its share price to close at $621, as a combination of pipeline setbacks and ongoing profitability concerns continued to unsettle investors.
